Global Personalized Medicine Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID : Maia- 19113381

Publishing Date : 09-Sep-2021

No. of pages : 110

PRICE
3000
6000


  • Personalized medicine, also termed Theranostics or precision medicine, is a medical procedure that separates patients into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.[1] The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept[1][2] though some authors and organisations use these expressions separately to indicate particular nuances.
    The Personalized Medicine market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

    Considering the influence of COVID-19 on the global Personalized Medicine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

    This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

    Under COVID-19 Outbreak, how the Personalized Medicine Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

    Major Players in Personalized Medicine market are:
    Biogen, Inc
    Exagen Diagnostics, Inc.
    Genelex Corporation
    QIAGEN
    Precision Biologics, Inc
    Asuragen, Inc.
    Decode Genetics, Inc.
    Celera Diagnostics LLC
    Dako A/S
    Danaher Corporation (Cepheid, Inc.)
    Exact Science Corporation
    GE Healthcare
    Illumina, Inc.
    Abbott Laboratories

    Most important types of Personalized Medicine products covered in this report are:
    PM Diagnostics
    PM Therapeutics
    Personalized Medical Care
    Personalized Nutrition & Wellness

    Most widely used downstream fields of Personalized Medicine market covered in this report are:
    Diagnostic Companies
    Pharmaceutical Companies
    Healthcare Companies
    Others

    Major Region

    s or countries covered in this report:
    North America
    Europe
    China
    Japan
    Middle East and Africa
    South America
    India
    South Korea
    Southeast Asia
    Others

    In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

    In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

    In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

    Years considered for this report:


    Historical Years:

    2016-2020

    Base Year:

    2020

    Estimated Year:

    2021

    Forecast Period:

    2021-2026

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports